disease have been described in the literature. The commonest such disease is lupus erythematosus, the. systemic form being slightly more common than the chronic discoid. The second most common association is persistent vasculitis. In two cases this was of the Henloch Schonlein type (anaphylactoid purpura). A miscellany of other conditions has been described and includes dermatomyositis, arthritis, membranous glomerulonephritis and Hodgkin's disease.
Case 1 is apparently unique in having a chronic vasculitis confined to the skin in an adult, although an interesting patient with the constellation of mononeuritis multiplex, arthritis, Raynaud's phenomenon, chronic vasculitis and an increased instance of infection has been described (Friend et al. 1975) . Case 2 has mild systemic lupus erythematosus with no evidence of renal involvement and as such would be typical of the systemic lupus erythematosus associated with C2 deficiency, which has recently been reviewed (Douglas et al. 1976 ).
C2 deficiency is inherited as an autosomal recessive characteristic. A tissue-typing study was first carried out in two families with C2 deficiency (Fu et al. 1974) . The associated HLA type in this study and others was HLA-10,-B 18. Case 1 has one haplotype with HLA-B18; unfortunately, his two brothers are untraceable. Case 2 has HLA-A3,-B7 and -AIO,-BW16 haplotypes; the latter is present in the mother and sisters who have half normal levels of C2. It is not yet clear whether deficiency of C2 causes an increased tendency to develop lupus erythematosus and vasculitis, but it is possible that a C2 deficient patient with circulating immune complexes might clear such complexes less readily because of a reduced ability to opsonize them with C3. Alternatively, genetic coding for the complement component may be located close to as yet unknown lymphocyte definable determinants on the same chromosome, which in turn might give rise to a particular immune response to a given antigen.
Dr J F Mowbray: We have found that a considerable number of presumed heterozygous deficiencies have atopies, in particular nickel sensitivity, and that of the homozygous deficiences, half do not have apparent disease. I believe that C2 deficiency leads to a persistence of circulating complexes, but one can not exclude the possibility that it acts only as an HLA marker for an immune response gene which is required for the immune complex disease.
Dr Cameron Kennedy: Where there are no facilities for estimating levels of-individual complement components it is well worth requesting the total hemolytic activity (CH50), since this depends on adequate quantities and function of all the components. It is essential that the serum used is fresh.
Myasthenia Gravis, Systemic Lupus Erythematosus and Urticaria (Case 1) C R Darley MRCP and D D Munro MD FRCP Myasthenia Gravis and Herpetiform Acantholysis (Case 2) C R Darley MRCP and P F Borrie MD FRCP (St Bartholomew's Hospital, London ECJ)
Case 1 Mrs B D, aged 46 years, developed myasthenia gravis in 1963. This has been well controlled with pyridostigmine and ephedrine. A thymectomy was performed in 1966 and histology showed the germinal centres which are characteristically seen in this disease. No thymoma was found. The only other relevant past history was an episode of angiocedema following Co-trimoxazole in 1972 the patient first noted urticaria; this was poorly controlled by a variety of antihistamine preparations and had become worse in late 1976.
Investigations: The antinuclear factor (ANF) has been positive since 1971 and at a titre of 1/1000 since 1973. Direct immunofluorescence of the uninvolved forearm skin in December 1976 showed IgG adherent to epidermal nuclei and IgM present on the dermo-epidermal junction. No complement was present. Striated muscle antibodies have been consistently negative.
Progress and treatment: In the last few months the urticaria has been well controlled on cyproheptadine hydrochloride and hydroxyzine hydrochloride.
Case 2 Mrs B H, aged 46 years, developed myasthenia gravis in 1957. It has remained easily controllable with pyridostigmine. There is no other relevant past history. In 1974 she developed a pruritic rash having the appearance of dermatitis herpetiformis (DH) (Fig 1) . antibodies have always been negative and upper mediastinal tomography showed no evidence of a thymoma. A skin biopsy in 1974 revealed acantholysis and intra-epidermal bulla formation (Fig 2) . In retrospect, eosinophilic spongiosis was present on an earlier biopsy in 1973 (Fig 3) . Direct immunofluorescence was inconclusive originally, but in January 1977 IgG and C3 were found in the epidermal intercellular region (Fig 4) . Indirect immunofluorescence was negative.
Progress and treatment: The patient has either failed to respond or developed side effects with the following: prednisone, azathioprine, methotrexate, dapsone, sulphapyridine, clofazimine and levamisole. Antihistamines do little to relieve the .sponiosi 
Discussion
These 2 cases are examples of the concurrence of myasthenia and autoimmune disease. This occurs more commonly than would be expected by chance. In systemic lupus erythematosus (SLE) non-organspecific antibodies are present, and in myasthenia gravis both organ-and non-organ-specific antibodies occur. About 30% have striated muscle antibodies and 20 % have a positive ANF. However, the finding of positive direct immunofluorescence at the dermo-epidermal junction in Case 1 supports the diagnosis of SLE. The episode of angiocedema following Co-trimoxazole may be significant, as drug sensitivity, notably to sulphonamides, is more common in SLE (Dubois 1974) . Urticaria is an unusual presenting feature of SLE. On the basis of Dubois' review of a number of large series in 1974 the incidence is less than 0.50%. However, it occurs at some stage of the disease in about 70% of cases. Prognostic predictions are impossible as there is no correlation between the course of the disease and the type of skin lesion; but in a large series, some of those presenting with cutaneous manifestations remained free of systemic involvement for up to fourteen years (Harvey et al. 1954) . SLE has been reported with thymoma and with myasthenia (Larsson 1963 , Makela et al. 1964 . The myasthenia commonly antedates the SLE. Interestingly, thymus histology in patients with SLE alone shows germinal centres similar to those seen in myasthenia. Since thymectomy may help myasthenia, it was tried as treatment for SLE, but no benefit was derived and in fact SLE has been reported following thymectomy.
The association of superficial pemphigus or pemphigus vulgaris with myasthenia and/or thymoma has been reported over 20 times (Maize et al. 1975 , Tagami et al. 1976 ). Pemphigus has always followed the onset of myasthenia gravis and has also occurred after thymectomy. Superficial pemphigus occurs more commonly than pemphigus vulgaris, which of course is not the case in normal practice. Pemphigus antibodies with myasthenia, thymoma or the two diseases together have been detected many months prior to the onset of any rash. Both pemphigus toliaceus and pemphigus erythematosus have been described with myasthenia, but it is pemphigus erythematosus which is of particular interest as it forms a link between pemphigus and SLE (Bean & Lynch 1970) . Pemphigus erythematosus not only has positive direct immunofluorescence present in the subcorneal epidermal intercellular zone and a circulating pemphigus antibody, but also positive immunofluorescence at the dermo-epidermal junction and a positive ANF. Clinically the rash has many features of SLE in that it often affects the upper trunk, neck and face. It may occur in a typical butterfly distribution and there is often an element of photosensitivity. Some patients have later developed classical SLE However, case 2 falls into a group called herpetiform acantholysis (Barranco 1974) . Although well described, this is only the second case reported in association with myasthenia, the first one being described by Tagami et al. (1976) . Clinically the rash has many features of DH, while histologically there is acantholysis and intra-epidermal bulla formation often preceded by eosinophilic spongiosis as seen in Case 2 (Emmerson & Wilson Jones 1968) . Direct immunofluorescence shows a positive reaction in the epidermal intercellular zone and positive indirect immunofluorescence has been found in some cases.
The mechanism by which these diseases arise remains unclear. The role of the thymus would seem to be fundamental and the release of hidden antigens following thymic disease is a possible explanation. However, cross reaction between the pemphigus antibody and Hassall's corpuscles has proved negative (Maize et al. 1975) . Another suggestion is that there is a defect in a group of T cells known as thymic suppressor cells, resulting in a failure to overcome autoimmune phenomena. Reports of mucocutaneous candidiasis in association with myasthenia and thymoma (Burstein 1974) give further support to the suggestion of T-cell impairment.
